UBS Group’s Tema Oncology ETF CANC Stock Holding History
Bought
Maintained
Sold
Other funds holding CANC
UBS Group's CANC Position: Q3 2026 in Review
UBS Group opened a new position in Tema Oncology ETF (CANC) in Q3 2026: 15,119 shares worth $635K. The stake represents ﹤0.01% of the portfolio and ranks #6034 among its holdings. This is a return to the name: UBS Group previously reported a position in CANC as recently as Q3 2025.
UBS Group first reported a position in CANC in Q1 2025 and has held it in 3 quarters since. 17 funds tracked by Wall St. Rank hold CANC as of Q3 2026.
- UBS Group held 15,119 shares of Tema Oncology ETF worth $635K as of Q3 2026.
- Tema Oncology ETF was a new UBS Group position in Q3 2026.
- Tema Oncology ETF made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #6034 holding.
- UBS Group first reported a position in Tema Oncology ETF in Q1 2025 and has held it in 3 quarters since.
- 17 funds tracked by Wall St. Rank held Tema Oncology ETF as of Q3 2026.
Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.